Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Yuan Chen

Showing results (81-90 of 163) with videos related to

Pageof 17
Sort By:
Theranostics|December 1, 2017
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-AnalysisRui You, Ying-Shu Cao, Pei-Yu Huang, et al.
JAMA Network Open|July 27, 2023
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical TrialQi Yang, Xiong Zou, Yu-Long Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction ChemotherapyQi Yang, Meng-Xia Zhang, Xiong Zou, et al.
Plos One|March 6, 2014
Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinomaXiang-Bo Wan, Rou Jiang, Fang-Yun Xie, et al.
Oral Oncology|August 23, 2021
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trialQi Yang, Le Xia, Mei Lin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2015
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification systemRui You, Xiong Zou, Shun-Lan Wang, et al.
Medical Oncology (Northwood, London, England)|July 16, 2014
Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinomaRou Jiang, Zhong-Han Yang, Dong-Hua Luo, et al.
Head & Neck|November 17, 2023
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinomaXiong Zou, Zheng-Kai Feng, Yi-Jun Hua, et al.
Med (New York, N.Y.)|October 9, 2025
TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trialTian-Liang Xia, Wenxuan Huang, You-Ping Liu, et al.
Chinese Journal of Cancer|June 13, 2015
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinomaRou Jiang, Xiu-Yu Cai, Zhong-Han Yang, et al.
Pageof 17

Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Theranostics|December 1, 2017
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-AnalysisRui You, Ying-Shu Cao, Pei-Yu Huang, et al.
JAMA Network Open|July 27, 2023
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical TrialQi Yang, Xiong Zou, Yu-Long Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction ChemotherapyQi Yang, Meng-Xia Zhang, Xiong Zou, et al.
Plos One|March 6, 2014
Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinomaXiang-Bo Wan, Rou Jiang, Fang-Yun Xie, et al.
Oral Oncology|August 23, 2021
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trialQi Yang, Le Xia, Mei Lin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2015
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification systemRui You, Xiong Zou, Shun-Lan Wang, et al.
Medical Oncology (Northwood, London, England)|July 16, 2014
Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinomaRou Jiang, Zhong-Han Yang, Dong-Hua Luo, et al.
Head & Neck|November 17, 2023
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinomaXiong Zou, Zheng-Kai Feng, Yi-Jun Hua, et al.
Med (New York, N.Y.)|October 9, 2025
TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trialTian-Liang Xia, Wenxuan Huang, You-Ping Liu, et al.
Chinese Journal of Cancer|June 13, 2015
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinomaRou Jiang, Xiu-Yu Cai, Zhong-Han Yang, et al.
Pageof 17